Genetic Complexity of Crohn’s Disease in Two Large Ashkenazi Jewish Families

Background & Aims Crohn’s disease (CD) is a highly heritable disease that is particularly common in the Ashkenazi Jewish population. We studied 2 large Ashkenazi Jewish families with a high prevalence of CD in an attempt to identify novel genetic risk variants. Methods Ashkenazi Jewish patients with CD and a positive family history were recruited from the University College London Hospital. We used genome-wide, single-nucleotide polymorphism data to assess the burden of common CD-associated risk variants and for linkage analysis. Exome sequencing was performed and rare variants that were predicted to be deleterious and were observed at a high frequency in cases were prioritized. We undertook within-family association analysis after imputation and assessed candidate variants for evidence of association with CD in an independent cohort of Ashkenazi Jewish individuals. We examined the effects of a variant in DUOX2 on hydrogen peroxide production in HEK293 cells. Results We identified 2 families (1 with >800 members and 1 with >200 members) containing 54 and 26 cases of CD or colitis, respectively. Both families had a significant enrichment of previously described common CD-associated risk variants. No genome-wide significant linkage was observed. Exome sequencing identified candidate variants, including a missense mutation in DUOX2 that impaired its function and a frameshift mutation in CSF2RB that was associated with CD in an independent cohort of Ashkenazi Jewish individuals. Conclusions In a study of 2 large Ashkenazi Jewish with multiple cases of CD, we found the genetic basis of the disease to be complex, with a role for common and rare genetic variants. We identified a frameshift mutation in CSF2RB that was replicated in an independent cohort. These findings show the value of family studies and the importance of the innate immune system in the pathogenesis of CD.

[1]  Judy H. Cho,et al.  A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF. , 2016, Gastroenterology.

[2]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[3]  S. Chakraborty,et al.  Engulfment pathways promote programmed cell death by enhancing the unequal segregation of apoptotic potential , 2015, Nature Communications.

[4]  Judy H. Cho,et al.  Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations , 2015, Nature Genetics.

[5]  D. Gale,et al.  Combinatorial Conflicting Homozygosity (CCH) analysis enables the rapid identification of shared genomic regions in the presence of multiple phenocopies , 2015, BMC Genomics.

[6]  Kenneth Offit,et al.  Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins , 2014, Nature Communications.

[7]  Timothy L. Tickle,et al.  Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. , 2014, The Journal of clinical investigation.

[8]  Terry M Therneau,et al.  The kinship2 R Package for Pedigree Data , 2014, Human Heredity.

[9]  Xin Li,et al.  Joint analysis of sequence data and single-nucleotide polymorphism data using pedigree information for imputation and recombination inference , 2014, BMC Proceedings.

[10]  D. G. MacArthur,et al.  Guidelines for investigating causality of sequence variants in human disease , 2014, Nature.

[11]  Shaun M. Purcell,et al.  Statistical power and significance testing in large-scale genetic studies , 2014, Nature Reviews Genetics.

[12]  Ross M. Fraser,et al.  A General Approach for Haplotype Phasing across the Full Spectrum of Relatedness , 2014, PLoS genetics.

[13]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[14]  R. Feakins,et al.  Ulcerative colitis or Crohn's disease? Pitfalls and problems , 2014, Histopathology.

[15]  Masato Kimura,et al.  NCBI’s Database of Genotypes and Phenotypes: dbGaP , 2013, Nucleic Acids Res..

[16]  H. Uhlig.  Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease , 2013, Gut.

[17]  J. Merchant,et al.  Dual oxidases control release of hydrogen peroxide by the gastric epithelium to prevent Helicobacter felis infection and inflammation in mice. , 2013, Gastroenterology.

[18]  J. Barrett,et al.  Using Genetic Prediction from Known Complex Disease Loci to Guide the Design of Next-Generation Sequencing Experiments , 2013, PloS one.

[19]  Jean-François Zagury,et al.  Haplotype estimation using sequencing reads. , 2013, American journal of human genetics.

[20]  Mauricio O. Carneiro,et al.  From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.

[21]  Judy H. Cho,et al.  Deep Resequencing of GWAS Loci Identifies Rare Variants in CARD9, IL23R and RNF186 That Are Associated with Ulcerative Colitis , 2013, PLoS genetics.

[22]  Judy H. Cho,et al.  Extended haplotype association study in Crohn’s disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-κB pathway gene, HEATR3 , 2013, Genes and Immunity.

[23]  Dorota Glowacka,et al.  SwiftLink: parallel MCMC linkage analysis using multicore CPU and GPU , 2013, Bioinform..

[24]  Doug Speed,et al.  Improved heritability estimation from genome-wide SNPs. , 2012, American journal of human genetics.

[25]  W. Sandborn,et al.  Crohn's disease , 2012, The Lancet.

[26]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[27]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[28]  E. Wijsman.  The role of large pedigrees in an era of high-throughput sequencing , 2012, Human Genetics.

[29]  L. Jostins,et al.  Defective tumor necrosis factor release from Crohn's disease macrophages in response to toll-like receptor activation: Relationship to phenotype and genome-wide association susceptibility loci , 2012, Inflammatory bowel diseases.

[30]  Jennifer Mulle,et al.  A Genome-Wide Scan of Ashkenazi Jewish Crohn's Disease Suggests Novel Susceptibility Loci , 2012, PLoS genetics.

[31]  Fiona Cunningham,et al.  A Combined Functional Annotation Score for Non-Synonymous Variants , 2012, Human Heredity.

[32]  John Quackenbush,et al.  Genome-wide siRNA screen for mediators of NF-κB activation , 2012, Proceedings of the National Academy of Sciences.

[33]  E. Lander,et al.  The mystery of missing heritability: Genetic interactions create phantom heritability , 2012, Proceedings of the National Academy of Sciences.

[34]  Subrata Ghosh,et al.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.

[35]  Itsik Pe'er,et al.  Implications for health and disease in the genetic signature of the Ashkenazi Jewish population , 2012, Genome Biology.

[36]  J. Marchini,et al.  Genotype Imputation with Thousands of Genomes , 2011, G3: Genes | Genomes | Genetics.

[37]  A. Gonzalez-Perez,et al.  Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. , 2011, American journal of human genetics.

[38]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[39]  C. Couture,et al.  Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations , 2011, European Respiratory Journal.

[40]  S. Brant.  Update on the heritability of inflammatory bowel disease: the importance of twin studies. , 2011, Inflammatory bowel diseases.

[41]  T. Nagayasu,et al.  Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB , 2010, Journal of Medical Genetics.

[42]  Sharon R Grossman,et al.  Integrating common and rare genetic variation in diverse human populations , 2010, Nature.

[43]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[44]  S. Warren,et al.  Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population , 2010, Proceedings of the National Academy of Sciences.

[45]  Daniel Rios,et al.  Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor , 2022 .

[46]  A. Segal,et al.  The immunopathogenesis of Crohn's disease: a three-stage model. , 2009, Current opinion in immunology.

[47]  P. Rosenstiel,et al.  DUOX2-derived reactive oxygen species are effectors of NOD2-mediated antibacterial responses , 2009, Journal of Cell Science.

[48]  T. Sweeting,et al.  Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease , 2009, The Journal of experimental medicine.

[49]  K. Gradel,et al.  Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. , 2009, Gastroenterology.

[50]  N. Saito,et al.  Duox maturation factors form cell surface complexes with Duox affecting the specificity of reactive oxygen species generation , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  J. Dumont,et al.  Activation of Dual Oxidases Duox1 and Duox2 , 2009, Journal of Biological Chemistry.

[52]  A. Cheifetz,et al.  How often is a diagnosis of ulcerative colitis changed to Crohn's disease and vice versa? , 2008, Inflammatory bowel diseases.

[53]  L. Persani,et al.  Biallelic inactivation of the dual oxidase maturation factor 2 (DUOXA2) gene as a novel cause of congenital hypothyroidism. , 2008, The Journal of clinical endocrinology and metabolism.

[54]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[55]  P. Rutgeerts,et al.  Familial Crohn's Disease in Belgium: Pedigrees, Temporal Relationships Among Cases, and Family Histories , 2007, Journal of clinical gastroenterology.

[56]  F. Miot,et al.  Missense mutations of dual oxidase 2 (DUOX2) implicated in congenital hypothyroidism have impaired trafficking in cells reconstituted with DUOX2 maturation factor. , 2007, Molecular endocrinology.

[57]  D. Clayton,et al.  An R Package for Analysis of Whole-Genome Association Studies , 2007, Human Heredity.

[58]  J. Dickinson,et al.  The advantages of dense marker sets for linkage analysis with very large families , 2007, Human Genetics.

[59]  S. Refetoff,et al.  Identification of the Maturation Factor for Dual Oxidase , 2006, Journal of Biological Chemistry.

[60]  Ralf Kittler,et al.  Evaluation of saliva as a source of human DNA for population and association studies. , 2006, Analytical biochemistry.

[61]  C. Panhuysen,et al.  Identification of genetic loci for basal cell nevus syndrome and inflammatory bowel disease in a single large pedigree , 2006, Human Genetics.

[62]  M. Cheang,et al.  A Population-Based Case Control Study of Potential Risk Factors for IBD , 2006, The American Journal of Gastroenterology.

[63]  William D. Lees,et al.  Defective acute inflammation in Crohn's disease: a clinical investigation , 2006, The Lancet.

[64]  Christine Klein,et al.  LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. , 2006, The New England journal of medicine.

[65]  Clive M. Onnie,et al.  Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease , 2005, The Lancet.

[66]  Daniel E. Weeks,et al.  Mega2: data-handling for facilitating genetic linkage and association analyses , 2005, Bioinform..

[67]  Christian Stehlik,et al.  PAN1/NALP2/PYPAF2, an Inducible Inflammatory Mediator That Regulates NF-κB and Caspase-1 Activation in Macrophages* , 2004, Journal of Biological Chemistry.

[68]  J. Hugot.  Inflammatory bowel disease: a complex group of genetic disorders. , 2004, Best practice & research. Clinical gastroenterology.

[69]  F. Alt,et al.  Deficiencies of GM-CSF and Interferon γ Link Inflammation and Cancer , 2003, The Journal of experimental medicine.

[70]  C. O'Morain,et al.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. , 2002, American journal of human genetics.

[71]  G. Abecasis,et al.  Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.

[72]  H. Ostrer.  A genetic profile of contemporary Jewish populations , 2001, Nature Reviews Genetics.

[73]  J. Satsangi,et al.  Review article: the genetics of inflammatory bowel disease. , 2001, Alimentary pharmacology & therapeutics.

[74]  Emden R. Gansner,et al.  An open graph visualization system and its applications to software engineering , 2000, Softw. Pract. Exp..

[75]  J. Satsangi,et al.  Genetics of inflammatory bowel disease. , 1994, Gut.

[76]  A. Segal,et al.  NEUTROPHIL DYSFUNCTION IN CROHN'S DISEASE , 1976, The Lancet.

[77]  P. Elwood,et al.  Milk antibodies and myocardial infarction [Letter] , 1974 .

[78]  P. Frankland.  On the Evolution of Heat During Muscular Action1 , 1878, Nature.